Brief: Editas Medicine Announces Chief Financial Officer Transition
20/03/2025 20:45
March 20 (Reuters) - Editas Medicine Inc EDIT.O: EDITAS MEDICINE ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION EDITAS MEDICINE INC - CFO ERICK J. LUCERA TO STEP DOWN EDITAS MEDICINE INC - AMY PARISON APPOINTED AS EDITAS CFO Source text: ID:nGNX7gYQC5 Further company coverage: EDIT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Editas Medicine
See all newsEditas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Editas Medicine, Inc. expected to post a loss of 27 cents a share - Earnings Preview
Editas Medicine Q2 net loss narrows and beats estimates
Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
Editas Medicine down after $125 mln stock-and-warrants offering